The role of big mitogen-activated protein kinase 1 (BMK1) / extracellular signal-regulated kinase 5 (ERK5) in the pathogenesis and progression of atherosclerosis

Journal of Pharmacological Sciences

Volumn 120, Issue 4, 2012, Pages 259-263

  Yoshizumi, Masanori ^a   Kyotani, Yoji ^a   Zhao, Jing ^a   Nagayama, Kosuke ^a   Ito, Satoyasu ^a   Tsuji, Yuichi ^a   Ozawa, Kentaro ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Big mitogen activated protein kinase 1 (BMK1) extracellular signal regulated kinase 5 (ERK5); Signal transduction; Vascular smooth muscle cell

Indexed keywords

HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 7; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA;

AORTA MEDIA; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; BRAIN INFARCTION; CELL MIGRATION; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; INFLAMMATION; KIDNEY DISEASE; NERVE FIBER GROWTH; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 84871482349     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12R11CP     Document Type: Review

References (28)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340:115-126. (Pubitemid 29054847)
2. Yoshizumi M, Tsuchiya K, Tamaki T. Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular disease. J Med Invest. 2001;48:11-24.
3. Abe J, Berk BC. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med. 1998;8:59-64. (Pubitemid 28127945)
4. Hayashi M, Lee JD. Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice. J Mol Med. 2004;82:800-808.
5. Nishimoto S, Nishida E. MAPK signaling: ERK5 versus ERK1/2. EMBO Rep. 2006;7:782-786. (Pubitemid 44275395)
6. Suzaki Y, Yoshizumi M, Kagami S, Koyama AH, Taketani Y, Houchi H, et al. Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells. Potential role in cell survival following oxidative insults. J Biol Chem. 2002;277:9614-9621. (Pubitemid 34953051)
7. Suzaki Y, Yoshizumi M, Kagami S, Nishiyama A, Ozawa Y, Kyaw M, et al. BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. Kidney Int. 2004;65:1749-1760. (Pubitemid 38591023)
8. Grotendorst GR, Seppa HE, Kleinman HK, Martin GR. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc Natl Acad Sci U S A. 1981;78:3669-3672. (Pubitemid 11062414)
9. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest. 1992;89:507-511.
10. Izawa Y, Yoshizumi M, Ishizawa K, Fujita Y, Kondo S, Kagami S, et al. Big mitogen-activated protein kinase 1 (BMK1)/extracellular signal-regulated kinase 5 (ERK5) is involved in plateletderived growth factor (PDGF)-induced vascular smooth muscle cell migration. Hypertens Res. 2007;30:1107-1117.
11. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res. 2000;86:494-501. (Pubitemid 30165039)
12. Griendling KK, Sorescu D, Lassègue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2000;20:2175-2183.
13. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;271:23317-23321. (Pubitemid 26314775)
14. Lambeth JD, Cheng G, Arnold RS, Edens WA. Novel homologs of gp91phox. Trends Biochem Sci. 2000;25:459-461.
15. Lassegue B, Sorescu D, Szöcs K, Yin Q, Akers M, Zhang Y, et al. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res. 2001;88:888-894. (Pubitemid 32441466)
16. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, et al. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation. 2005;112:2677-2685. (Pubitemid 41532605)
17. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Tamaki T. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res. 2001;24:251-261. (Pubitemid 32577147)
18. Pruodfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro. Circ Res. 2000;87:1055-1062.
19. Zhao J, Kyotani Y, Itoh S, Nakayama H, Isosaki M, Yoshizumi M. Big mitogen-activated protein kinase 1 protects cultured rat aortic smooth muscle cell from oxidative damage. J Pharmacol Sci. 2011;116:173-180.
20. Brown MT, Cooper JA. Regulation, substrates and functions of src. Biochem Biophys Acta. 1996;1287:121-149. (Pubitemid 26189191)
21. Wang X, Toumier C. Regulation of cellular functions by the ERK5 signaling pathway. Cell Signal. 2006;18:753-760. (Pubitemid 43208930)
22. Cavanaugh JE, Ham J, Hetman M, Poser S, Yan C, Xia Z. Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and camp in neurons. J Neurosci. 2001;21:434-443. (Pubitemid 32107434)
23. Kamakura S, Moriguchi T, Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem. 1999;274:26563-26571.
24. Yan C, Takahashi M, Okuda M, Lee JD, Berk BC. Fluid shear stress stimulates big mitogen-activated protein kinase 1 (BMK1) activity in endothelial cells. Dependence on tyrosine kinases and intracellular calcium. J Biol Chem. 1999;274:143-150. (Pubitemid 29035041)
25. Pi X, Yan C, Berk BC. Big mitogen-activated protein kinase 1 (BMK1)/ERK5 protects endothelial cells from apoptosis. Circ Res. 2004;94:362-369. (Pubitemid 38240728)
26. Li L, Tatake RJ, Natarajan K, Taba Y, Garin G, Tai C, et al. Fluid shear stress inhibits TNF-mediated JNK activation via MEK5-BMK1 in endothelial cells. Biochem Biophys Res Commun. 2008;370:159-163.
27. Liu G, Miyata K, Hitomi H, Yao L, Sun GP, Suzaki Y, et al. Involvement of mineralocorticoid receptor in high glucose-induced big mitogen-activated protein kinase 1 activation and mesangial cell proliferation. J Hypertens. 2010;28:536-542.
28. Urushihara M, Takamatsu M, Shimizu M, Kondo S, Kinoshita Y, Suga K, et al. ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis. Am J Physiol Renal Physiol. 2010;298:F167-F176.